Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Post by Endeavor48on Jan 07, 2020 12:36pm
288 Views
Post# 30526496

Ok...I talked to IR for over half an hour..

Ok...I talked to IR for over half an hour..They basically told me the same as the other poster but I was told the delay is about the equipment used and exactly how it works.They said they were going to provide a "demonstration" of the process in the very near future to satisfy the FDA's concerns..Now with regard to P1 and 2..I was told if there was anything "material" we would hear about it and that the trial was going as expected..I took from that they (P1-2) are doing well,but this is only my opinion..I pressed hard to get more info and was told there are more N.R's in the pipeline and we should hear something soon.BTW she also said the quarterly updates in no way take the place of any n.rs they are going to be releasing.I spoke with a lady in IR and she was very polite...fwiw..
Bullboard Posts